Author

A. Akilzhanova

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

WHOLE-EXOME SEQUENCING OF MONOZYGOTIC TWINS WITH EPILEPSY AND AUTISM SPECTRUM DISORDER IN A KAZAKHSTANI FAMILY: A CASE REPORT

A Kazakhstani family with 9-year-old monozygotic twin girls who developed focal seizures with secondary generalization at approximately one year of age and were subsequently diagnosed with ASD is described, illustrating the distinction between candidate variants and a molecular diagnosis.

A. Gabdulkayum, Z. Mirmanova, A. Daniyarov et al. · Eurasian journal of applied... · 0 citations

Review Open access 2026

Plant-Derived DPP-4 Inhibitors in Cardiometabolic Diseases: A Critical Evaluation of the Evidence Base and Priorities for Kazakhstan

The increasing prevalence of obesity, type 2 diabetes mellitus, and associated cardiometabolic complications has intensified the challenge of effectively controlling disturbances in carbohydrate metabolism and highlighted the need for new therapeutic targets and approaches. One promising target is the enzyme DPP-4, whi...

K. Zhapar, D. Samatkyzy, D. I. Valishaeva et al. · BULLETIN of the L.N. Gumilyo... · 0 citations

Review Open access Sep 2026

Plant-Derived Dipeptidyl Peptidase-4 Inhibitors in Cardiometabolic Disorders: A Critical Review of Natural Scaffolds and Experimental Evidence

Cardiometabolic disorders, including obesity, insulin resistance and type 2 diabetes mellitus, remain major biomedical problems closely linked to vascular complications. Dipeptidyl peptidase-4 (DPP-4) is a clinically validated therapeutic target because inhibition of this enzyme prolongs the activity of incretin hormon...

K. Zhapar, D. Samatkyzy, Diana Valishayeva et al. · Biomedicines · 0 citations